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Abstract
Background: P21 is a secreted protein expressed in all developmental stages of Trypanosoma cruzi. The aim of this study
was to determine the effect of the recombinant protein based on P21 (P21-His6) on inflammatory macrophages during
phagocytosis.
Findings: Our results showed that P21-His6 acts as a phagocytosis inducer by binding to CXCR4 chemokine receptor and
activating actin polymerization in a way dependent onthe PI3-kinase signaling pathway.
Conclusions: Thus, our results shed light on the notion that native P21 is a component related to T. cruzi evasion from the
immune response and that CXCR4 may be involved in phagocytosis. P21-His6 represents an important experimental control
tool to study phagocytosis signaling pathways of different intracellular parasites and particles.
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Introduction
Phagocytosis is the way by which macrophages internalize
foreign particles and cellular debris. A diverse repertoire of
receptors expressed by macrophages allows them to respond to a
variety of external stimuli. Immune receptors come in a variety of
classes, such as the well-characterized phagocytic Fcc receptor
(FccR) and the complement receptor (CR). Much of our
understanding of phagocytic signaling comes from studies on
FccR-mediated phagocytosis, which is a spatially and temporally
coordinated series of events initiated by the binding of an
opsonized IgG particle with FccR that leads to actin polymeri-
zation and the formation of pseudopods that extend around the
particle to form a phagocytic cup. The pseudopods then
completely surround the particle forming a phagosome, which is
then internalized and its contents degraded (for review: [1]).
To promote phagocytosis, macrophages must be recruited,
where chemokines play a crucial role during this process.
Nonetheless, the signaling pathways for the various chemokines,
leading to efficient chemotaxis of macrophages, are not yet well
characterized [1]. Chemokines act through the G protein coupled
receptor (GPCR) superfamily, such as CCR5 and CXCR4.
Ligand binding to GPCRs induces conformational changes of the
receptor that are transmitted to the cytoplasmic domains of the
protein, enabling the protein to couple with an intracellular
heterotrimeric G protein. The intracellular G protein acts as an
intracellular signal by activating or inhibiting cytoplasmic
enzymes. CCR5 was first isolated as a functional GPCR that is
antagonized by various CC chemokines. CXCR4 was originally
identified as an orphan receptor called leukocyte-derived seven
transmembrane domain receptor (LESTR), but did not receive
much attention until its isolation as a coreceptor for HIV-1 and the
discovery of its natural ligand, SDF-1/CXCL12. In their function
as HIV coreceptors, CCR5 and CXCR4 physically associate with
CD4-activated gp120, which undergoes a conformational change
that in turn exposes a hidden coreceptor-binding site. Binding of
gp120 to the coreceptor brings the envelope into close proximity to
the cell surface and induces gp120 to undergo a second
conformational change that allows the gp41 protein to penetrate
the cell membrane and form a six-helix array. Through processes
that are still unknown, fusion occurs between the cell and viral
membranes allowing entry of the viral capsid and proteins (for
review: [2]).
F-actin is required for CD4 and CXCR4 redistribution, and it
has been shown that activated moesin promotes F-actin redistri-
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bution and CD4-CXCR4 clustering, which are required for
efficient X4-tropic HIV-1 infection in permissive lymphocytes [3].
Also, authors have proposed that Arf6 (ADP ribosylation factor 6)
GTP/GDP activity has synergy with the key first HIV-1/receptor
interactions by maintaining PIP2-associated membrane dynamics
to promote efficient viral fusion and entry in a clathrin-
independent manner [4]. Moreover, CXCR4 and CD74 lead to
macrophage migration inhibitory factor (MIF) endocytosis [5],
and RpkA, a highly conserved GPCR of Dictyostelium discoideum,
plays a role in phagocytosis and anti-bacterial defense [6]. Thus,
these data suggest that GPCRmay play important role during
phagocytosis in addition to the traditionally well-described
functions related to chemotaxis, adhesion, cell survival and
proliferation. Moreover, it has been shown that the uptake of
Yersinia pestis by macrophages lacking CCR5 is significantly
decreased [7].
Trypanosoma cruzi can infect and replicate in macrophages.
During invasion, T. cruzi interacts with different macrophage
receptors to induce its own phagocytosis. However, the nature
of those receptors and the molecular mechanisms involved are
poorly understood. The phagocytosis of tissue culture-derived
trypomastigotes (TCT) is mediated by macrophage Pronase-
sensitive membrane components. Also, there is indirect evidence
that FccR and CR participate in T. cruzi phagocytosis but are
not essential [8]. Moreover, T. cruzi amastigote forms interact
with both the macrophage mannose receptor and mannose-
binding proteins in a way that facilitates the adhesion of
amastigotes to macrophages [9]. Recently, authors have shown
that phagocytosis induced by T. cruzi infection involves Toll-like
receptor (TLR) 2 but are independent of TLR4 receptors [10].
In addition, a previous report suggested that once the surface
components of T. cruzi trypomastigotes are recognized by
macrophage receptors, they trigger the activation of a tyrosine
phosphorylation cascade, PI3-kinase recruitment, and assembly
of actin filaments at the site of initial cell-to-cell contact,
resembling the events described during phagocytosis [11].
We have recently characterized a novel T. cruzi protein whose
role during parasite cell invasion is not completely understood.
First, we searched T. cruzi genomic database for species-specific
hypothetical proteins that showed a high probability of being
secreted or membrane-anchored and thus likely to be involved in
host-cell invasion. A sequence that codes for a 21-kDa protein with
a high probability of being secreted was selected. After cloning this
protein sequence, we found that it was a ubiquitous secreted
protein of T. cruzi. The recombinant form (P21-His6) adhered to
HeLa cells in a dose-dependent manner. Also, HeLa cell treatment
with P21-His6 augmented invasion by T. cruzi metacyclic
trypomastigotes and extracellular amastigotes [12]. Since P21
promoted T. cruzi cell invasion, we examined its potential to
enhance the phagocytosis of zymosan particles and protozoan
parasites by mouse inflammatory macrophages. Our results
suggested that P21-His6 binds to CXCR4 expressed in macro-
phages and acts as a phagocytosis inducer by activating actin
polymerization in a way dependent on the PI3-kinase signaling
pathway. This is the first study that shows a possible role of
CXCR4 in mediating phagocytosis and that P21-His6 may
represent an important experimental tool to elucidate the signaling
pathway for the phagocytosis of particles and intracellular
parasites.
Results
P21-His6 Upregulates Zymosan Phagocytosis
To determine if P21-His6 would upregulate phagocytosis, we
incubated C57BL/6 peritoneal macrophages with different
concentrations of P21-His6 and zymosan particles. We also tested
40 mg/ml of the recombinant protein at different time points. P21-
His6 increased phagocytosis in a dose- and time- independent
manner. Incubation with BSA showed no impact on macrophage
phagocytosis activity (Figure 1A, B). Since P21-His6 was purified
from Escherichia coli, we needed to ascertain that the observed
phenotype was due to the recombinant protein activity per se and
not to residual bacterial LPS. Thus, we performed the zymosan
phagocytosis assay in the presence of polymyxin B, using
macrophages derived from toll-42/2 mice. The results showed
that the pro-phagocytic activity observed was in fact due to the
effect of P21-His6 on the macrophages (Figure 1C). Also, we
performed similar uptake experiments using denatured P21-His6,
which showed a significantly lower zymosan uptake (Figure 1D). In
addition, previous incubation of the recombinant protein with
anti-P21-His6 polyclonal antibody decreased phagocytosis to basal
levels in FcR-blocked macrophages (Figure 1E). On the other
hand, macrophages without FcR blocking also showed high
phagocytosis rates.Pre-immune serum sample at the same dilutions
as anti-P21-His6 did not affect P21-His6 activity (data not shown).
P21-His6 Induces Macrophage Actin Polymerization
Phagocytosis is a process dependent on actin polymerization.
Hence, peritoneal macrophages wereincubated with 40 mg/ml of
P21-His6 for 30 minutes and 1 and 2 hours and afterwards stained
with TRITC-phalloidin. Cell samples were then analyzed by flow
cytometry to determine the status of actin polymerization by
measuring fluorescence intensity. Actin polymerization was
increased as assessed by the intensity of phalloidin labeling of
treated cells when compared to untreated controlmacrophages
(Figure 2 A, B).Also, anti-P21-His6 polyclonal antibody abolished
actin polymerization only in FcR-blocked macrophages (Figure 2
A, B). After 3 hours of treatment, the recombinant protein lost its
activity (Figure 2 C). A pre-immune serum sample at the same
dilutions as anti-P21-His6 did not affect P21-His6 activity (data not
shown).
P21-His6 Regulates Phagocytosis and Actin
Polymerization by Activating the PI3-kinase Signaling
Pathway
Phagocytosis assays in the presence or absence ofP21-His6as
well as different signaling pathway inhibitors showed that the pro-
phagocytic activity of P21-His6 depended on the PI3-kinase
signaling pathway (Figure 3 A). The recombinant protein did not
show pro-phagocytic activity in macrophages treated with PI3-
kinase inhibitor. Although a small statistically significant difference
was observed for macrophages treated with m-Tor and ERK 2
inhibitors, the recombinant protein still showed high pro-
phagocytic activity almost reaching its performance rates com-
pared to untreated control macrophages. Thus, the statistical
significance of the effects observed for the m-Tor and ERK2
signaling pathways did not seem to be correlated to a major
biological impact on pro-phagocytic property of P21-His6 (Figure 3
D, G). Moreover, in macrophages treated with AKT, n-Ras, MEK
1 or MEK1/2, P21-His6 induced phagocytosis to a similar extent
as the untreated control cells (Figure 3 B, C, E, F).
Phagocytosis Upregulated by P21-His6
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Figure 1. P21-His6 enhances phagocytosis of zymosan particles. Phagocytosis assay using zymosan particles treated or not with P21-His6. (A)
peritoneal macrophages, treated in different periods,1, 3, 6, 12, 24 and 48 hours. P21-His6 enhanced zymosan internalization, in all treatment periods.
(B) Peritoneal macrophages (grey bar), treated with BSA (white bars) or P21-His6 (black bars) at different concentrations: 1, 20, 40 and 80 mg/ml. P21-
His6, but not BSA, enhanced zymosan internalization at all concentrations tested. (C) Peritoneal macrophages obtained from wild-type (WT) or toll42/
2 animals, treated or not with P21-His6, and those also treated with polymyxin B. P21-His6 treatment increased zymosan phagocytosis in both, the WT
and toll42/2 macrophages. Also, treatment with polymyxin B did not inhibit P21-His6 activity. (D) Phagocytosis assay using folded and denatured P21-
His6 (dP21-His6) at 100uC. Note that only folded protein was able to upregulate phagocytosis. (E) Peritoneal macrophages with (white bars) or without
(black bars) FcR blocked were incubated with P21-His6 (40 mg/ml) previously opsonized in different concentrations of serum. Peritoneal macrophages
with FcR did not show an enhanced zymosan internalization as those without FcR blocked. *P,0.05 **P,0.01 ***P,0.001.
doi:10.1371/journal.pone.0051384.g001
Phagocytosis Upregulated by P21-His6
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P21-His6 Binds to CXCR4 Chemokine Receptor
We hypothesized that a GPCR would be the mammalian cell
receptor for the protein. To gain insight into this aspect, we
performed the zymosan phagocytosis assay using macrophages
treated or not with AMD3100 (CXCR4 inhibitor) and macro-
phages from ccr42/2mice in the presence or absence of P21-His6.
Host cell treatment with CXCR4 inhibitor completely abolished
P21-His6 pro-phagocytic activity (Figure 4 A, B) indicating
CXCR4 could be the macrophage receptor for P21-His6. We
also performed Western blotting of peritoneal macrophages
treated or not with P21-His6to determine the amount of CXCR4
expression. Band densitometry showed that CXCR4 expression
Figure 2. Peritoneal macrophages treated with P21-His6 show increased actin polymerization. Peritoneal macrophages were treated or
not with P21-His6 for 0.5, 1.0 and 3.0 hours in the presence or not of anti-P21-His6 polyclonal antibody and FcR blocking. The actin cytoskeleton was
stained with TRITC-phalloidin. Flow cytometry showed that the cells treated with the recombinant protein had a higher fluorescence intensity than
the control cells following 0.5 (A) and 1.0 hour (B) of incubation. After 3.0 hours of incubation, the protein lost its activity (C). Representative
histograms are also shown. Macrophages not treated with P21-His6 (D); macrophages treated with P21-His6 (E); macrophages with FcR-blocking and
treated with P21-His6 previously incubated with anti-P21-His6 polyclonal antibody (F).*P,0.5, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0051384.g002
Phagocytosis Upregulated by P21-His6
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was increased in macrophages treated with P21-His6 (Figure 4 C).
Taken together, these results strengthened the idea that the
receptor for the recombinant protein in macrophages is CXCR4.
P21-His6 Increases Phagocytosis of Different Intracellular
Parasites
Finally, we turned our attention to the possible effect of the
recombinant protein on Leishmania amazonensis and Toxoplasma
gondii uptake by macrophages. Here, we used T. cruzi extracellular
amastigotes as the positive control [12]. The results obtained
confirmed our hypothesis that P21-His6 upregulates phagocytosis
by macrophages. In macrophages treated with P21-His6, there was
a threefold increase in the phagocytosis of T. cruzi extracellular
amastigotes and also a fourfold and fivefold increase in the uptake
of L. amazonensis promastigotes and T. gondii tachyzoites, respec-
tively (Figure 5).
Discussion
Endocytosis is essential for virtually all eukaryotic cells to
internalize nutrients, antigens, pathogens, and cell surface
receptors from the plasma membrane into membrane-bounded,
endocytic vesicles to regulate cell homeostasis, cell signaling, and
development. Distinct mechanisms mediate endocytic uptake of a
large variety of different-sized cargoes ranging from small
molecules to viruses or bacteria [13]. In this context, macrophages
are strategically located throughout body tissues, where they ingest
and process foreign materials, dead cells and debris and recruit
additional macrophages in response to inflammatory signals
[14].Moreover, authors have identified a small GTPase effector
protein, IQGAP1, as a novel diacylglycerol kinase (DGKf)-
associated complex protein, and DGKfhas been found to be
involved in IQGAP1/Rac1-mediated bacterialphagocytosis upon
LPS stimulation in macrophages [15].
Here we evaluated the potential of a recombinant protein based
on T. cruzi P21 in upregulating phagocytosis, its putative
macrophage receptor and the signaling pathway triggered upon
P21-His6 interaction with the host cell.Our results showed that
P21-His6 is able to upregulate phagocytosis in a way dependent on
binding to CXCR4 actin polymerization and the signaling
pathway triggered by PI3-kinase.
P21-His6 pro-phagocytic activity depended neither on time of
incubation nor protein concentration. Also, polyclonal antibody
anti-P21-His6, denaturated protein, polymyxin treatment and the
use of peritoneal macrophages derived from toll42/2 mice
confirmed that the pro-phagocytic activity observed in different
assays was due to the recombinant protein and not to residual LPS
from the bacterial extract. Experiments performed without FcR
Figure 3. P21-His6 activity depends on PI3-kinase pathway. Peritoneal macrophages were incubated with zymosan, treated or not with P21-
His6, and also treated or not with inhibitors to PI3-kinase (A), AKT (B), n-Ras (C), ERK 2 (D), MEK 1 (E), MEK1/2 (F), m-Tor (G). P21-His6 activity was not
detected in the presence of PI3-K inhibitor. *P,0.5, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0051384.g003
Figure 4. P21-His6 binds to CXCR4 chemokine receptor. CCR4 knockout did not affect P21-His6 pro-phagocytic activity (A). CXCR4 inhibitor
abolished the pro-phagocytic P21-His6 activity (B). Peritoneal macrophages treated with P21-His6 showed an increased expression of CXCR4 revealed
by Western blotting (C). *P,0.5, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0051384.g004
Phagocytosis Upregulated by P21-His6
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blocking showed an increased phagocytosis probably due to the
cross-linking of FcR by the immune complex.
Actin assembly during phagocytosiscreates protrusions that
encompass extracellular materials. Actin also supports the
processes of invagination of a membrane segment into the
cytoplasm, elongation of the invagination, scission of the new
vesicle from the plasma membrane, and movement of the vesicle
away from the membrane [16]. Accordingly, macrophage actin
polymerization triggered by P21-His6 was demonstrated by flow
cytometry. The results supported our findings, since P21-His6
triggered actin polymerization at the time points studied and since
this activity was completely abolished following treatment with
anti-P21-His6 and FcR blocking of macrophages.
Turning our attention to the putative signaling pathway
triggered upon P21-His6 interaction with peritoneal macrophages,
our results using inhibitors of different signaling pathways showed
that P21-His6 relies on the PI3-kinase signaling pathway in a way
independentof AKT. This intriguing result is supported by other
studies [17,18]. Studies have demonstrated that PI3K-dependent
signal transduction of Rho-family GTPase activities occurs during
FcR-mediated phagocytosis and that PI3K-dependent deactiva-
tion of Cdc42 is necessary for phagocytosis. Moreover, the
activities of PI3K and Cdc42 are linked: FcR-activated Cdc42
stimulates PI3K, which increases concentrations of PI(3,4,5)P3 in
phagocytic cups, allowing the PI(3,4,5)P3-dependent deactivation
of Cdc42 that is necessary for completion of phagocytosis [19]. In
addition, a study has provided important evidence on PI3-kinase
activation during T. cruzi cell invasion [20]. Also, we observed a
small statistical difference during zymosan phagocytosis by
macrophages that were previously treated with m-Tor and
ERK2 inhibitors in the presence of P21-His6. Besides, the
recombinant protein showed high pro-phagocytic activity. Thus,
these results indicated that these signaling pathways may not be
too relevant for the biological process triggered by P21-His6. We
have a study underway to better understand P21-His6 signaling
process, using besides inhibitors, other approaches such as
Western blotting of phosphorylated proteins, PCR array and
phosflow kits.
Considering the variety of cell surface receptors, we hypothe-
sized that GPCRs could be the host cell receptor for P21-His6
according to recently published studies [6,7]. We performed
experiments using peritoneal macrophages from ccr42/2mice and
using CXCR4 inhibitor. Our results from experiments using
CXCR4 inhibitor showed that CXCR4 could be the P21-His6
receptor in macrophages. As a GPCR, the mechanism of CXCR4
receptor activation is mediated by coupling to an intracellular
heterotrimeric G-protein associated with the inner surface of the
plasma membrane [21,22]. CXCR4 signaling during chemotaxis,
adhesion, cell survival and proliferation has been shown to involve
PI3-kinase, AKT, MAPK, the Ras-activated signaling pathway
and mammalian target of rapamycin complex 1 (mTORC1) [22–
25]. On the other hand, the signaling pathway triggered during
CXCR4-dependent phagocytosis is largely unknown, since this is
the first report to consider CXCR4 as a phagocytosis mediating
receptor. This issue will be further investigated in novel studies
from our group.
Recombinant DNA technology has allowed scientists to prepare
large amounts of proteins based on their native ones to study the
putative activity of the native protein. This study revealed that P21
may be an important T. cruzi host immune response evasion factor.
P21 pro-phagocytic activity may allow the parasite its intracellular
permanence, where it can disrupt the phagolysosome compart-
ment and grow freely in the host cell cytoplasm. Moreover, a well-
known activity of a recombinant protein may turn out to be an
alternative control tool for biologists to study processes possibly
activated by another protein. For instance, the recombinant form
of metacyclic trypomastigotes gp82 induces apoptotic cell death in
melanoma cells [26]. We thus believe that P21 represents a novel
tool for scientists to study phagocytosis.
All together, our results showed that P21-His6 upregulates
phagocytosis and actin cytoskeleton remodeling by binding to
CXCR4 receptor and signaling via PI3-kinase. Also, the
recombinant protein activity sheds light on the possible role of
the T. cruzi native P21 in regulating parasite escape from host
immune response by giving the circulating parasites the chance to
invade the host cell and multiply in the cytoplasm.
Methods
Reagents
PI3-kinase inhibitor, LY294002 (Cell Signaling), concentration:
50 mM, time of treatment: one hour prior to phagocytosis.
Ras – farnesyl thiosalicylic acid inhibitor (Cayman Chemical
Company: 10010501), concentration: 50 mM, time of treatment:
one hour prior to phagocytosis.
Akt inhibitor (Calbiochem: 124005), concentration: 25 mM,
time of treatment: one hour prior to phagocytosis.
MEK 1/2 U0126 inhibitor (Cell Signaling: 9903), concentra-
tion: 10 mM, time of treatment: two hours prior to phagocytosis.
Figure 5. P21-His6 augments phagocytosis of different intracellular parasites. Peritoneal macrophages were incubated with Trypanosoma
cruzi, Leishmania amazonensis or Toxoplasma gondii and treated or not with P21-His6. The number of internalized parasites in treated cells was higher
than in control cells, indicating that P21-His6 increases parasite internalization. *P,0.5, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0051384.g005
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MEK 1 inhibitor PD98059 (Cell Signaling: 9900S), concentra-
tion: 50 mM, time of treatment: one hour prior to phagocytosis.
5-Iodotubercidin (ITU) (Santa Cruz Biotechnology: sc3531),
concentration: 20 mM, time of treatment: one hour prior to
phagocytosis.
Rapamycin (FRAP/mTOR inhibitor) and ERK2 inhibitor –
(Cell Signaling), concentration: 10 nM, time of treatment: one
hour prior to phagocytosis.
CXCR4 inhibitor - AMD 3100 octahydrochloride (MERCK),
concentration: 30 mM, time of treatment: 30 minutes prior to
phagocytosis.
TRITC-phalloidin -(Sigma-Aldrich: P5282), dilution: 1:1500.
Polymyxin B (Sigma-Aldrich: 81271) (25 mg/ml). Time of
treatment: 30 minutes prior to phagocytosis.
Bovine serum albumin (Sigma-Aldrich) was used as a control for
P21-His6 at the same concentrations and time of incubation.
Ethics
Maintenance and care of animals complied with the guidelines
of the Laboratory Animal Ethics Committee from the Universi-
dade Federal de Uberlaˆndia. Animal euthanasia was performed in
accordance with international welfare grounds, according to the
American Veterinary Medical Association Guidelines on Eutha-
nasia. This study was approved by the ethics committee of animal
research from Universidade Federal de Uberlaˆndia (process:
CEUA/UFU 105/10).
Animals
Male wild-type C57BL/6, ccr42/2 C3H/HePas and toll-42/2
mice were provided and maintained at the animal facilities of the
Department of Biochemistry and Immunology, School of Medi-
cine of Ribeira˜o Preto, USP (Ribeira˜o Preto, Brazil). Male mice
were six to eight weeks old and were kept under standard
conditions on a 12-h light-dark cycle in a temperature-controlled
room (2562uC) with food and water ad libitum.
Parasite Culture
Promastigotes of Leishmania (Leishmania) amazonensis (IFLA/BR/
67/PH8) were cultivated in Schneider’s Insect Medium (LGC
Biotecnologia), supplemented with 10% fetal bovine serum (FBS;
Cultilab, Campinas, Brazil), 100 mg/mL gentamicin and 2 mM L-
glutamine (Gibco BRL-Life Technologies, New York, USA), at
26uC. Parasites in stationary phase were used for the experimental
infection in macrophages. The parasites were maintained infective
by periodic hamster footpad inoculations. Extracellular amasti-
gotes from the T. cruzi G strain were obtained after differentiation
of TCT in LIT medium, pH 5.8, overnight as previously
described (Silva et al., 2006). Tachyzoites of the RH strain of
Toxoplasma gondii were harvested from the peritoneal cavities of
out-bred Swiss Webster mice that had been injected with 107
organisms 2 days earlier.
P21-His6 Purification
P21-His6 (GenBank: EU004210.1) was purified as previously
described [12]. The quality of purification was demonstrated by
SDS-PAGE.
Peritoneal Macrophage Culture and Invasion Assays
Peritoneal macrophages from 6- to 8-week-oldmale C57BL/6
mice were harvested with 3 mL of Dulbecco’s modified Eagle’s
medium (DMEM) from the peritoneal cavity of stimulated mice
(1–3 mL of 3% thioglycollate medium; Gibco, Gaithersburg, MD;
3 days before) (mouse inflammatory macrophage). The cells were
centrifuged and adjusted to 16106/mL in DMEM supplemented
with 12.5 mM HEPES, 2 g/L sodium bicarbonate, 2 mM L-
glutamine, 50 mg/mL gentamicin and 10% FBS (complete
medium). The cells were seeded in 24-well flat-bottomed plates
(Corning Corporation; Cambridge, MA, USA) at a density of
26105/200 mL/well and then incubated overnight in a humidified
atmosphere with 5% CO2 at 37uC to allow the cells to adhere.
Afterwards, 10 zymosan particles or 10 amastigotes of T. cruzi G
strain or 20 promastigotes of L. amazonensis or 5 tachyzoites of T.
gondii RH strain were added for each macrophage plated on a
round coverslip in the presence or not of 40 mg/ml P21-His6. The
parasites and zymosan particles were left in contact with
macrophages for 2 hours and then washed with PBS, fixed in
Bouin’s solution and Giemsa stained. In inhibitor- treated cells,
treatment was performed according to the manufacturers’direc-
tions prior to the addition of zymosan particles. For the
experiments with anti-P21-His6 polyclonal antibody, the recom-
binant protein was incubated or not with different dilutions of the
polyclonal antibody for 30 minutes in DMEM and then used
during zymosan phagocytosis assays using peritoneal macrophages
with or without FcR blocking. For FcR blocking, serum samples
from healthy C57BL/6 mice were diluted in DMEM (1:20) and
incubated with seeded macrophages for 30 minutes and then
washed 3 times with PBS. Also, pre-immune serum samples were
used as control for anti-P21-His6 antibody. Results were expressed
as the number of internalized parasites or particles/100 cells.
F-actin Staining
Inflammatory macrophages were recruited in vivo by intraper-
itoneal thioglycollate inoculation. After three days, cells were
harvested from the mouse peritoneal cavity, washed 3 times with
PBS, counted and adjusted to 16106 cells/mL in PBS. Macro-
phages with FcR blocking were pre-treated for 30 minutes with
serum (1:20 dilution) obtained from healthy C57BL/6 mice. The
cells (FcR blocked or not) were then incubated with P21-His6,
opsonized (anti-P21-His6) or not for different time periods: 30
minutes and one and three hours. The opsonized protein was
obtained by incubating with serum of immunized C57BL/6 mice
diluted 1:10, 1:40 and 1:80, for 30 minutes. The cells were fixed
with 4% formaldehyde, washed 3 times and then left in PBS. F-
actin staining was performed using TRITC-phalloidin diluted
1:1000 in PBS+saponin (0.01%). After washing, samples were
analyzed by FACSCantoII (BD) and the results were obtained
using FlowJo software (version 7.6.3).
Western Blotting
To determine if the treatment of macrophages withP21-His6
would upregulate CXCR4 expression, 107 peritoneal macrophag-
es were seeded in a 6-well plate and treated or not with P21-
His6for one hour. Following three PBS washes, macrophages were
removed with a cell scraper and lysed in electrophoresis buffer
(Santa Cruz Biotechnology). After SDS-PAGE and electrophoretic
protein transfer, the membrane was incubated with anti-CXCR4
(Santa Cruz Biotechnology) followed by horseradish peroxidase-
conjugated secondary antibody (Sigma-Aldrich). The CXCR4
band was detected by chemiluminescence, and densitometry was
performed using ImageJ software. Similar amounts of spotted
extracts were checked with anti-b-actin antibody (Sigma-Aldrich).
Statistical Analysis
The significance of differences was determined by one-way
ANOVA performed according to the VassarStats program
(Richard Lowry 1998–2006), available at http://faculty.vassar.
edu/lowry/VassarStats.html or using the GraphPad Prism
Phagocytosis Upregulated by P21-His6
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program, version 5.01 for Student-t analysis. The differenceswere
considered significant when p,0.05. All experiments were
performed 4 to 8 times in triplicate.
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